BREZTRI (budesonide, glycopyrrolate, and formoterol fumarate)

**Product type:** Human Prescription Drug

**Active ingredient:** BUDESONIDE; FORMOTEROL; GLYCOPYRROLATE

**Strength:** 160; 4.8; 9 ug/1; ug/1; ug/1

**Dosage form:** Aerosol, Metered

**Route:** Respiratory (Inhalation)

**Labeler:** AstraZeneca Pharmaceuticals LP

**Marketing category:** NDA (NDA212122)

**Pharmacologic class:** Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]